Panah Parab, Ronit Juthani, Kala Seetharaman. "Inclusion of patients with reduced performance status (ECOG 2 or higher) in FDA registrational trials for urothelial cancer.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.5_suppl.680